Digital Biology & Genetics

High-Throughput Screening Market Present Scenario and the Growth Prospects with Forecast 2024 – healthcarenewswires blog

High-Throughput Screening Market The global high-throughput screening market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure, increasing research and development activities, launch of technologically advanced products that are miniaturized

[ Read More ]

The Prospects of Behavioral Genetics: Bad Genes Behind Crimes, Precision Education And Loosing Free Will?

We strongly believe that only digital health can bring healthcare into the 21st century and make patients the point-of-care. Can the warrior gene explain aggressive and violent acts so that lawyers base their defenses on that in courts? Can genetics determine whether your marriage will be a long-lasting companionship? What about alcoholism, depression or autism?

[ Read More ]

Brainstorm Health: Digital Health Ethics, Google Opioid Project, CRISPR Babies

Stanford and a compendium of industry partners has set out to create guiding principles meant to ensure the ethical use of digital health technology, Stanford Libraries tells Fortune.Stanford Universitys sprawling library system recently hosted a seminar attended by stakeholders in the digital health field, such as Proteus Digital Health (maker of the first FDA approved

[ Read More ]

Global Alliance for Genomics and Health picks 7 data initiatives for 2019

The Global Alliance for Genomics and Health has chosen seven genomic data initiatives from around the world as new Driver Projects for 2019 projects where researches will work together develop and pilo standards for the sharing genomic and other health data.Those projects are:Human Heredity and Health in AfricaGEnome Medical alliance JapanEuropean Joint Programme on Rare

[ Read More ]

Why You Should Be Careful About 23andMes Health Test

Last month, the DNA-testing company 23andMe secured Food and Drug Administration approval for a new screening for gene-based health risks. Along with celiac disease, Alzheimers, Parkinsons, breast cancer and several other medical conditions, the company can now screen clients for two mutations that have been linked to colorectal cancer.But F.D.A.-approved does not necessarily mean clinically

[ Read More ]